These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29425281)

  • 1. AT1 Receptor Antagonism Improves Structural, Functional, and Biomechanical Properties in Resistance Arteries in a Rodent Chronic Kidney Disease Model.
    Quek KJ; Ameer OZ; Phillips JK
    Am J Hypertens; 2018 May; 31(6):696-705. PubMed ID: 29425281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amlodipine Improves Vessel Function and Remodeling in the Lewis Polycystic Kidney Rat Mesenteric Artery.
    Quek KJ; Ameer OZ; Phillips JK
    Am J Hypertens; 2020 Jul; 33(7):634-643. PubMed ID: 32215654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Angiotensin II Receptor Blockade Limits Hypertension, Aortic Dysfunction, and Structural Remodeling in a Rat Model of Chronic Kidney Disease.
    Ameer OZ; Butlin M; Kaschina E; Sommerfeld M; Avolio AP; Phillips JK
    J Vasc Res; 2016; 53(3-4):216-229. PubMed ID: 27880955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive vascular remodelling, endothelial dysfunction and stiffness in mesenteric resistance arteries in a rodent model of chronic kidney disease.
    Quek KJ; Boyd R; Ameer OZ; Zangerl B; Butlin M; Murphy TV; Avolio AP; Phillips JK
    Vascul Pharmacol; 2016 Jun; 81():42-52. PubMed ID: 26771067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective cardiorenal effects of spironolactone in a rodent model of polycystic kidney disease.
    Jeewandara TM; Ameer OZ; Boyd R; Wyse BF; Underwood CF; Phillips JK
    Clin Exp Pharmacol Physiol; 2015 Apr; 42(4):353-60. PubMed ID: 25676668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing changes in thoracic and abdominal aortic biomechanical properties in rodent models of vascular calcification and hypertension.
    Ameer OZ; Salman IM; Avolio AP; Phillips JK; Butlin M
    Am J Physiol Heart Circ Physiol; 2014 Jul; 307(2):H143-51. PubMed ID: 24838503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of anemia and its relationship with renal function, blood pressure, and erythropoietin in rats with chronic kidney disease.
    Phillips JK; Boyd R; Krockenberger MB; Burgio G
    Vet Clin Pathol; 2015 Sep; 44(3):342-54. PubMed ID: 26292198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of losartan on differential reflex control of sympathetic nerve activity in chronic kidney disease.
    Yao Y; Hildreth CM; Farnham MM; Saha M; Sun QJ; Pilowsky PM; Phillips JK
    J Hypertens; 2015 Jun; 33(6):1249-60. PubMed ID: 25764047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities associated with progressive aortic vascular dysfunction in chronic kidney disease.
    Ameer OZ; Boyd R; Butlin M; Avolio AP; Phillips JK
    Front Physiol; 2015; 6():150. PubMed ID: 26042042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibitor limits pulse-wave velocity and aortic calcification in a rat model of cystic renal disease.
    Ng K; Hildreth CM; Avolio AP; Phillips JK
    Am J Physiol Renal Physiol; 2011 Nov; 301(5):F959-66. PubMed ID: 21865263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal development of baroreceptor dysfunction in a rodent model of chronic kidney disease.
    Hildreth CM; Kandukuri DS; Goodchild AK; Phillips JK
    Clin Exp Pharmacol Physiol; 2013 Jul; 40(7):458-65. PubMed ID: 23662737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal central control underlies impaired baroreflex control of heart rate and sympathetic nerve activity in female Lewis polycystic kidney rats.
    Salman IM; Phillips JK; Ameer OZ; Hildreth CM
    J Hypertens; 2015 Jul; 33(7):1418-28. PubMed ID: 26039532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aortic stiffness is associated with vascular calcification and remodeling in a chronic kidney disease rat model.
    Ng K; Hildreth CM; Phillips JK; Avolio AP
    Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1431-6. PubMed ID: 21478483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of AT1 angiotensin-receptor blockade on structure and function of small arteries in SHR.
    Li JS; Sharifi AM; Schiffrin EL
    J Cardiovasc Pharmacol; 1997 Jul; 30(1):75-83. PubMed ID: 9268224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopeptidase Inhibition Corrects the Structure and Function of the Small Arteries in Experimental Renal Insufficiency.
    Haltia O; Törmänen S; Eräranta A; Jokihaara J; Nordhausen K; Rysä J; Ruskoaho H; Tikkanen I; Mustonen J; Pörsti I
    J Vasc Res; 2015; 52(2):94-102. PubMed ID: 26184548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats : effects of angiotensin receptor antagonism and converting enzyme inhibition.
    Intengan HD; Thibault G; Li JS; Schiffrin EL
    Circulation; 1999 Nov; 100(22):2267-75. PubMed ID: 10578002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic kidney disease impairs renal nerve and haemodynamic reflex responses to vagal afferent input through a central mechanism.
    Salman IM; Hildreth CM; Phillips JK
    Auton Neurosci; 2017 May; 204():65-73. PubMed ID: 27776979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal relationship between renal cyst development, hypertension and cardiac hypertrophy in a new rat model of autosomal recessive polycystic kidney disease.
    Phillips JK; Hopwood D; Loxley RA; Ghatora K; Coombes JD; Tan YS; Harrison JL; McKitrick DJ; Holobotvskyy V; Arnolda LF; Rangan GK
    Kidney Blood Press Res; 2007; 30(3):129-44. PubMed ID: 17446713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AT1 receptor blockade improves vasorelaxation in experimental renal failure.
    Kööbi P; Kalliovalkama J; Jolma P; Rysä J; Ruskoaho H; Vuolteenaho O; Kähönen M; Tikkanen I; Fan M; Ylitalo P; Pörsti I
    Hypertension; 2003 Jun; 41(6):1364-71. PubMed ID: 12743014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic treatment with tempol does not significantly ameliorate renal tissue hypoxia or disease progression in a rodent model of polycystic kidney disease.
    Ding A; Kalaignanasundaram P; Ricardo SD; Abdelkader A; Witting PK; Broughton BR; Kim HB; Wyse BF; Phillips JK; Evans RG
    Clin Exp Pharmacol Physiol; 2012 Nov; 39(11):917-29. PubMed ID: 23006058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.